首页> 外文期刊>Computational and Structural Biotechnology Journal >A Gene Module-Based eQTL Analysis Prioritizing Disease Genes and Pathways in Kidney Cancer
【24h】

A Gene Module-Based eQTL Analysis Prioritizing Disease Genes and Pathways in Kidney Cancer

机译:基于基因模块的eQTL分析优先考虑肾脏癌的疾病基因和途径

获取原文
           

摘要

Clear cell renal cell carcinoma (ccRCC) is the most common and most aggressive form of renal cell cancer (RCC). The incidence of RCC has increased steadily in recent years. The pathogenesis of renal cell cancer remains poorly understood. Many of the tumor suppressor genes, oncogenes, and dysregulated pathways in ccRCC need to be revealed for improvement of the overall clinical outlook of the disease. Here, we developed a systems biology approach to prioritize the somatic mutated genes that lead to dysregulation of pathways in ccRCC. The method integrated multi-layer information to infer causative mutations and disease genes. First, we identified differential gene modules in ccRCC by coupling transcriptome and protein-protein interactions. Each of these modules consisted of interacting genes that were involved in similar biological processes and their combined expression alterations were significantly associated with disease type. Then, subsequent gene module-based eQTL analysis revealed somatic mutated genes that had driven the expression alterations of differential gene modules. Our study yielded a list of candidate disease genes, including several known ccRCC causative genes such as BAP1 and PBRM1 , as well as novel genes such as NOD2, RRM1, CSRNP1, SLC4A2, TTLL1 and CNTN1. The differential gene modules and their driver genes revealed by our study provided a new perspective for understanding the molecular mechanisms underlying the disease. Moreover, we validated the results in independent ccRCC patient datasets. Our study provided a new method for prioritizing disease genes and pathways.
机译:透明细胞肾细胞癌(ccRCC)是肾细胞癌(RCC)的最常见和最具攻击性的形式。近年来,RCC的发病率稳定增长。肾细胞癌的发病机理仍知之甚少。 ccRCC中的许多肿瘤抑制基因,癌基因和失调的途径都需要揭示,以改善疾病的整体临床前景。在这里,我们开发了一种系统生物学方法来对导致ccRCC途径失调的体细胞突变基因进行优先排序。该方法集成了多层信息以推断出致病突变和疾病基因。首先,我们通过转录组和蛋白质-蛋白质相互作用来鉴定ccRCC中的差异基因模块。这些模块中的每个模块都由参与相似生物学过程的相互作用基因组成,它们的组合表达改变与疾病类型显着相关。然后,基于基因模块的后续eQTL分析揭示了驱动突变基因模块表达改变的体细胞突变基因。我们的研究列出了候选疾病基因,包括几个已知的ccRCC致病基因,例如BAP1和PBRM1,以及新基因,例如NOD2,RRM1,CSRNP1,SLC4A2,TTLL1和CNTN1。我们的研究揭示的差异基因模块及其驱动基因为理解该疾病的分子机制提供了新的视角。此外,我们在独立的ccRCC患者数据集中验证了结果。我们的研究提供了一种对疾病基因和途径进行优先排序的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号